annual CFF:
-$2.20B-$410.40M(-22.93%)Summary
- As of today (August 18, 2025), REGN annual cash flow from financing activities is -$2.20 billion, with the most recent change of -$410.40 million (-22.93%) on December 31, 2024.
- During the last 3 years, REGN annual CFF has fallen by -$1.19 billion (-118.78%).
- REGN annual CFF is now -672.68% below its all-time high of $384.25 million, reached on December 31, 2011.
Performance
REGN Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$1.13B-$39.00M(-3.58%)Summary
- As of today (August 18, 2025), REGN quarterly cash flow from financing activities is -$1.13 billion, with the most recent change of -$39.00 million (-3.58%) on June 30, 2025.
- Over the past year, REGN quarterly CFF has dropped by -$650.10 million (-135.98%).
- REGN quarterly CFF is now -284.35% below its all-time high of $612.00 million, reached on September 30, 2020.
Performance
REGN quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$3.99B-$650.10M(-19.48%)Summary
- As of today (August 18, 2025), REGN TTM cash flow from financing activities is -$3.99 billion, with the most recent change of -$650.10 million (-19.48%) on June 30, 2025.
- Over the past year, REGN TTM CFF has dropped by -$2.70 billion (-210.41%).
- REGN TTM CFF is now -1137.58% below its all-time high of $384.25 million, reached on December 31, 2011.
Performance
REGN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
REGN Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.9% | -136.0% | -210.4% |
| 3 y3 years | -118.8% | -1015.9% | -615.0% |
| 5 y5 years | -772.9% | +56.8% | -51.4% |
REGN Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -118.8% | at low | -2495.3% | +0.6% | -615.0% | at low |
| 5 y | 5-year | -772.9% | at low | -284.4% | +56.8% | -2141.1% | at low |
| alltime | all time | -672.7% | at low | -284.4% | +56.8% | -1137.6% | at low |
REGN Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$1.13B(+3.6%) | -$3.99B(+19.5%) |
| Mar 2025 | - | -$1.09B(-4.1%) | -$3.34B(+51.6%) |
| Dec 2024 | -$2.20B(+22.9%) | -$1.14B(+79.1%) | -$2.20B(+45.6%) |
| Sep 2024 | - | -$634.00M(+32.6%) | -$1.51B(+17.7%) |
| Jun 2024 | - | -$478.10M(-1115.1%) | -$1.28B(-9.6%) |
| Mar 2024 | - | $47.10M(-110.6%) | -$1.42B(-20.6%) |
| Dec 2023 | -$1.79B(+77.4%) | -$446.10M(+9.5%) | -$1.79B(+12.5%) |
| Sep 2023 | - | -$407.30M(-33.7%) | -$1.59B(-16.6%) |
| Jun 2023 | - | -$614.20M(+90.4%) | -$1.91B(+36.7%) |
| Mar 2023 | - | -$322.50M(+30.3%) | -$1.40B(+38.4%) |
| Dec 2022 | -$1.01B(+0.3%) | -$247.60M(-65.8%) | -$1.01B(-39.5%) |
| Sep 2022 | - | -$725.00M(+617.1%) | -$1.67B(+199.1%) |
| Jun 2022 | - | -$101.10M(-256.3%) | -$557.60M(-3.0%) |
| Mar 2022 | - | $64.70M(-107.1%) | -$574.70M(-42.9%) |
| Dec 2021 | -$1.01B(-49.0%) | -$906.60M(-335.2%) | -$1.01B(+148.7%) |
| Sep 2021 | - | $385.40M(-426.1%) | -$404.50M(+127.4%) |
| Jun 2021 | - | -$118.20M(-67.7%) | -$177.90M(-93.3%) |
| Mar 2021 | - | -$366.40M(+20.0%) | -$2.67B(+35.6%) |
| Dec 2020 | -$1.97B(+681.6%) | -$305.30M(-149.9%) | -$1.97B(-2.0%) |
| Sep 2020 | - | $612.00M(-123.4%) | -$2.01B(-23.7%) |
| Jun 2020 | - | -$2.61B(-878.5%) | -$2.63B(+7136.0%) |
| Mar 2020 | - | $335.60M(-197.1%) | -$36.40M(-85.6%) |
| Dec 2019 | -$252.10M(+227.0%) | -$345.70M(+3042.7%) | -$252.10M(-2486.0%) |
| Sep 2019 | - | -$11.00M(-28.1%) | $10.57M(-58.2%) |
| Jun 2019 | - | -$15.30M(-112.8%) | $25.28M(-13.9%) |
| Mar 2019 | - | $119.90M(-244.4%) | $29.37M(-138.1%) |
| Dec 2018 | -$77.10M(+216.0%) | -$83.03M(-2335.7%) | -$77.10M(-62.3%) |
| Sep 2018 | - | $3.71M(-133.1%) | -$204.60M(-5.5%) |
| Jun 2018 | - | -$11.21M(-183.5%) | -$216.51M(+201.6%) |
| Mar 2018 | - | $13.43M(-106.4%) | -$71.78M(+194.2%) |
| Dec 2017 | -$24.40M(-96.5%) | -$210.53M(+2468.8%) | -$24.40M(-92.0%) |
| Sep 2017 | - | -$8.20M(-106.1%) | -$305.54M(+13.7%) |
| Jun 2017 | - | $133.52M(+119.6%) | -$268.67M(-38.0%) |
| Mar 2017 | - | $60.81M(-112.4%) | -$433.39M(-38.1%) |
| Dec 2016 | -$700.39M(+166.5%) | -$491.68M(-1814.7%) | -$700.39M(+229.3%) |
| Sep 2016 | - | $28.68M(-191.9%) | -$212.72M(-63.8%) |
| Jun 2016 | - | -$31.20M(-84.9%) | -$587.04M(+7.7%) |
| Mar 2016 | - | -$206.19M(+5044.5%) | -$545.16M(+107.4%) |
| Dec 2015 | -$262.80M(+25.6%) | -$4.01M(-98.8%) | -$262.80M(-48.6%) |
| Sep 2015 | - | -$345.65M(-3333.4%) | -$511.55M(+219.8%) |
| Jun 2015 | - | $10.69M(-86.0%) | -$159.97M(-33.9%) |
| Mar 2015 | - | $76.17M(-130.1%) | -$242.05M(+15.7%) |
| Dec 2014 | -$209.27M(-371.3%) | -$252.76M(-4362.4%) | -$209.27M(-240.4%) |
| Sep 2014 | - | $5.93M(-108.3%) | $149.06M(+1.6%) |
| Jun 2014 | - | -$71.39M(-165.5%) | $146.66M(-16.0%) |
| Mar 2014 | - | $108.95M(+3.2%) | $174.57M(+126.3%) |
| Dec 2013 | $77.14M(-179.0%) | $105.56M(+2887.9%) | $77.14M(-176.0%) |
| Sep 2013 | - | $3.53M(-108.1%) | -$101.44M(-5.0%) |
| Jun 2013 | - | -$43.48M(-477.3%) | -$106.78M(+56.2%) |
| Mar 2013 | - | $11.52M(-115.8%) | -$68.37M(-30.0%) |
| Dec 2012 | -$97.65M(-125.4%) | -$73.01M(+3935.9%) | -$97.65M(-129.0%) |
| Sep 2012 | - | -$1.81M(-64.4%) | $336.80M(-0.5%) |
| Jun 2012 | - | -$5.08M(-71.4%) | $338.33M(-4.3%) |
| Mar 2012 | - | -$17.75M(-104.9%) | $353.46M(-8.0%) |
| Dec 2011 | $384.25M(+57.9%) | $361.44M(<-9900.0%) | $384.25M(+86.9%) |
| Sep 2011 | - | -$279.00K(-102.8%) | $205.57M(-0.9%) |
| Jun 2011 | - | $10.05M(-22.9%) | $207.46M(+3.7%) |
| Mar 2011 | - | $13.04M(-92.9%) | $200.13M(-17.7%) |
| Dec 2010 | $243.31M(+675.8%) | $182.76M(>+9900.0%) | $243.31M(+193.6%) |
| Sep 2010 | - | $1.61M(-40.7%) | $82.88M(-0.6%) |
| Jun 2010 | - | $2.72M(-95.2%) | $83.41M(+2.5%) |
| Mar 2010 | - | $56.22M(+151.8%) | $81.36M(+159.4%) |
| Dec 2009 | $31.36M(-116.3%) | $22.33M(+939.5%) | $31.36M(-129.4%) |
| Sep 2009 | - | $2.15M(+222.0%) | -$106.68M(-0.8%) |
| Jun 2009 | - | $667.00K(-89.3%) | -$107.51M(-43.0%) |
| Mar 2009 | - | $6.22M(-105.4%) | -$188.54M(-2.2%) |
| Dec 2008 | -$192.86M | -$115.72M(-8840.1%) | -$192.86M(-181.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2008 | - | $1.32M(-101.6%) | $237.09M(+0.4%) |
| Jun 2008 | - | -$80.37M(-4323.1%) | $236.11M(-26.1%) |
| Mar 2008 | - | $1.90M(-99.4%) | $319.35M(-0.0%) |
| Dec 2007 | $319.40M(+72.3%) | $314.23M(>+9900.0%) | $319.40M(+72.4%) |
| Sep 2007 | - | $347.00K(-87.9%) | $185.30M(-0.4%) |
| Jun 2007 | - | $2.87M(+46.4%) | $186.02M(+1.1%) |
| Mar 2007 | - | $1.96M(-98.9%) | $183.94M(-0.8%) |
| Dec 2006 | $185.40M(+4443.0%) | $180.13M(>+9900.0%) | $185.40M(+2152.2%) |
| Sep 2006 | - | $1.07M(+36.0%) | $8.23M(+13.5%) |
| Jun 2006 | - | $787.00K(-77.0%) | $7.25M(+12.1%) |
| Mar 2006 | - | $3.42M(+15.4%) | $6.47M(+58.5%) |
| Dec 2005 | $4.08M(-8.1%) | $2.96M(+3187.8%) | $4.08M(+110.3%) |
| Sep 2005 | - | $90.00K(+4400.0%) | $1.94M(+86.1%) |
| Jun 2005 | - | $2000.00(-99.8%) | $1.04M(-23.9%) |
| Mar 2005 | - | $1.03M(+25.8%) | $1.37M(-69.2%) |
| Dec 2004 | $4.44M(-95.9%) | $819.00K(-201.4%) | $4.44M(-45.9%) |
| Sep 2004 | - | -$808.00K(-345.6%) | $8.21M(-86.0%) |
| Jun 2004 | - | $329.00K(-92.0%) | $58.54M(-8.2%) |
| Mar 2004 | - | $4.10M(-10.6%) | $63.79M(-41.0%) |
| Dec 2003 | $108.18M(+6178.8%) | $4.59M(-90.7%) | $108.18M(+3.8%) |
| Sep 2003 | - | $49.52M(+788.1%) | $104.19M(+90.8%) |
| Jun 2003 | - | $5.58M(-88.5%) | $54.62M(+11.1%) |
| Mar 2003 | - | $48.50M(+8064.5%) | $49.16M(+2753.3%) |
| Dec 2002 | $1.72M(-99.5%) | $594.00K(-1337.5%) | $1.72M(-99.1%) |
| Sep 2002 | - | -$48.00K(-140.0%) | $192.41M(-0.2%) |
| Jun 2002 | - | $120.00K(-88.6%) | $192.85M(-1.6%) |
| Mar 2002 | - | $1.06M(-99.4%) | $196.03M(-43.9%) |
| Dec 2001 | $349.12M(+275.9%) | $191.28M(>+9900.0%) | $349.12M(+121.4%) |
| Sep 2001 | - | $398.00K(-87.9%) | $157.68M(-9.8%) |
| Jun 2001 | - | $3.29M(-97.9%) | $174.84M(-28.4%) |
| Mar 2001 | - | $154.15M(<-9900.0%) | $244.34M(+163.1%) |
| Dec 2000 | $92.87M(>+9900.0%) | -$161.00K(-100.9%) | $92.87M(-0.3%) |
| Sep 2000 | - | $17.55M(-75.9%) | $93.19M(+23.6%) |
| Jun 2000 | - | $72.80M(+2621.4%) | $75.41M(+3081.8%) |
| Mar 2000 | - | $2.67M(+1521.2%) | $2.37M(+672.0%) |
| Dec 1999 | $307.00K(-121.9%) | $165.00K(-171.7%) | $307.00K(-308.8%) |
| Sep 1999 | - | -$230.00K(-4.2%) | -$147.00K(-33.8%) |
| Jun 1999 | - | -$240.00K(-139.2%) | -$222.00K(-34.9%) |
| Mar 1999 | - | $612.00K(-311.8%) | -$341.00K(-75.7%) |
| Dec 1998 | -$1.40M(-103.6%) | -$289.00K(-5.2%) | -$1.40M(-36.6%) |
| Sep 1998 | - | -$305.00K(-15.0%) | -$2.21M(-15.1%) |
| Jun 1998 | - | -$359.00K(-20.2%) | -$2.61M(-106.5%) |
| Mar 1998 | - | -$450.00K(-59.1%) | $39.95M(+1.4%) |
| Dec 1997 | $39.42M(-40.6%) | -$1.10M(+57.1%) | $39.40M(-21.2%) |
| Sep 1997 | - | -$700.00K(-101.7%) | $50.00M(+0.4%) |
| Jun 1997 | - | $42.20M(-4320.0%) | $49.80M(-23.5%) |
| Mar 1997 | - | -$1.00M(-110.5%) | $65.10M(-1.8%) |
| Dec 1996 | $66.32M(+232.6%) | $9.50M(-1155.6%) | $66.30M(-15.6%) |
| Sep 1996 | - | -$900.00K(-101.6%) | $78.60M(-0.3%) |
| Jun 1996 | - | $57.50M(>+9900.0%) | $78.80M(+282.5%) |
| Mar 1996 | - | $200.00K(-99.1%) | $20.60M(+3.5%) |
| Dec 1995 | $19.94M(-8595.4%) | $21.80M(-3214.3%) | $19.90M(-5075.0%) |
| Sep 1995 | - | -$700.00K(0.0%) | -$400.00K(0.0%) |
| Jun 1995 | - | -$700.00K(+40.0%) | -$400.00K(-20.0%) |
| Mar 1995 | - | -$500.00K(-133.3%) | -$500.00K(+150.0%) |
| Dec 1994 | -$234.70K(-100.5%) | $1.50M(-314.3%) | -$200.00K(-91.3%) |
| Sep 1994 | - | -$700.00K(-12.5%) | -$2.30M(-104.7%) |
| Jun 1994 | - | -$800.00K(+300.0%) | $49.40M(-1.0%) |
| Mar 1994 | - | -$200.00K(-66.7%) | $49.90M(+0.2%) |
| Dec 1993 | $49.81M(-6436.6%) | -$600.00K(-101.2%) | $49.80M(-0.8%) |
| Sep 1993 | - | $51.00M(<-9900.0%) | $50.20M(-4663.6%) |
| Jun 1993 | - | -$300.00K(0.0%) | -$1.10M(+10.0%) |
| Mar 1993 | - | -$300.00K(+50.0%) | -$1.00M(+25.0%) |
| Dec 1992 | -$786.10K(-100.9%) | -$200.00K(-33.3%) | -$800.00K(+33.3%) |
| Sep 1992 | - | -$300.00K(+50.0%) | -$600.00K(+100.0%) |
| Jun 1992 | - | -$200.00K(+100.0%) | -$300.00K(+200.0%) |
| Mar 1992 | - | -$100.00K | -$100.00K |
| Dec 1991 | $91.53M | - | - |
FAQ
- What is Regeneron Pharmaceuticals, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. annual CFF year-on-year change?
- What is Regeneron Pharmaceuticals, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. quarterly CFF year-on-year change?
- What is Regeneron Pharmaceuticals, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. TTM CFF year-on-year change?
What is Regeneron Pharmaceuticals, Inc. annual cash flow from financing activities?
The current annual CFF of REGN is -$2.20B
What is the all time high annual CFF for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high annual cash flow from financing activities is $384.25M
What is Regeneron Pharmaceuticals, Inc. annual CFF year-on-year change?
Over the past year, REGN annual cash flow from financing activities has changed by -$410.40M (-22.93%)
What is Regeneron Pharmaceuticals, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of REGN is -$1.13B
What is the all time high quarterly CFF for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high quarterly cash flow from financing activities is $612.00M
What is Regeneron Pharmaceuticals, Inc. quarterly CFF year-on-year change?
Over the past year, REGN quarterly cash flow from financing activities has changed by -$650.10M (-135.98%)
What is Regeneron Pharmaceuticals, Inc. TTM cash flow from financing activities?
The current TTM CFF of REGN is -$3.99B
What is the all time high TTM CFF for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high TTM cash flow from financing activities is $384.25M
What is Regeneron Pharmaceuticals, Inc. TTM CFF year-on-year change?
Over the past year, REGN TTM cash flow from financing activities has changed by -$2.70B (-210.41%)